Trials / Completed
CompletedNCT01710345
Safety and Efficacy of Sufentanil NanoTab for Management of Acute Pain Following Bunionectomy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- Talphera, Inc · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a dose-finding study to determine if the sublingual administration of the Sufentanil NanoTab is safe and effective in the treatment of post-operative pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sufentanil NanoTab 20 mcg | |
| DRUG | Sufentanil NanoTab 30 mcg | |
| DRUG | Placebo NanoTab |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2012-10-19
- Last updated
- 2015-01-26
- Results posted
- 2015-01-26
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01710345. Inclusion in this directory is not an endorsement.